Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes.

Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'.

Serum brain-derived neurotrophic factor levels in different neurological diseases.

Biomarkers and attention-deficit/hyperactivity disorder: a systematic review and meta-analyses.

ErbB3 mRNA leukocyte levels as a biomarker for major depressive disorder.

Exome sequencing followed by large-scale genotyping suggests a limited role for moderately rare risk factors of strong effect in schizophrenia.

PCLO gene: its role in vulnerability to major depressive disorder.

A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial.

Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy.

Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project.

Possible influence of a non-synonymous polymorphism located in the NGF precursor on susceptibility to late-onset Alzheimer's disease and mild cognitive impairment.

Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels.

Alterations of brain-derived neurotrophic factor serum levels in patients with alcohol dependence.

BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects.

Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients.